$237.10+26.15% · 3M
Moving avg
1W-0.53%
1M+17.51%
3M+27.05%
6M+14.61%
YTD+36.43%
1Y+32.87%
3Y+75.42%
5Y+56.65%
52-week range
$165.7899% of range$237.78
Company health
Value2/6
Growth2/6
Profitability3/6
Health3/6
Dividend5/6
Bull vs bear
Strengths
- High return on equity (1449%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$26.17B
Enterprise value
$31.36B
P/E ratio (TTM)
24.24x
P/S ratio (TTM)
2.21x
EV/EBITDA
15.62x
Per share & returns
EPS (TTM)
$9.65
Dividend yield
1.44%
Beta (1Y)
0.57
30-day change
+17.51%
Trading
Volume (24h)
139.67K
Previous close
$237.77
Shares outstanding
110.37M
About Quest Diagnostics Incorporated
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
DGX
Quest Diagnostics Incorporated is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker DGX.
Frequently asked questions
What is Quest Diagnostics Incorporated's market cap?
Quest Diagnostics Incorporated (DGX) has a market capitalization of $26.17B.
What is Quest Diagnostics Incorporated's P/E ratio?
Quest Diagnostics Incorporated trades at a price-to-earnings (P/E) ratio of 24.24.
What exchange does DGX trade on?
DGX trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,218.31-0.16%
$1.15T cap
Johnson & JohnsonJNJ
$261.30+0.17%
$629.71B cap
AbbVie Inc.ABBV
$250.30+0.62%
$442.23B cap
UnitedHealth Group IncorporatedUNH
$402.11-0.86%
$365.17B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.70+1.34%
$332.68B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.76B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap